Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules.
Awada A, Giacchetti S, Gerard B, Eftekhary P, Lucas C, De Valeriola D, Poullain MG, Soudon J, Dosquet C, Brillanceau MH, Giroux B, Marty M, Bleiberg H, Calvo F, Piccart M.
Awada A, et al.
Ann Oncol. 2002 Dec;13(12):1925-34. doi: 10.1093/annonc/mdf321.
Ann Oncol. 2002.
PMID: 12453862
Free article.
Clinical Trial.